🇺🇸 FDA
Patent

US 12357623

Method for treating a disease or condition using a pyrazole compound or formulation thereof

granted A61KA61K31/4439A61K31/5377

Quick answer

US patent 12357623 (Method for treating a disease or condition using a pyrazole compound or formulation thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/4439, A61K31/5377, A61K31/675, A61K45/06